Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Hypercholesterolemia, eligibility for lipid-lowering therapy and therapeutic success: population-based study in a Portuguese urban population
Publication

Publications

Hypercholesterolemia, eligibility for lipid-lowering therapy and therapeutic success: population-based study in a Portuguese urban population

Title
Hypercholesterolemia, eligibility for lipid-lowering therapy and therapeutic success: population-based study in a Portuguese urban population
Type
Article in International Scientific Journal
Year
2008
Authors
Alves L
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Azevedo A
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Vol. 159
Pages: 755-760
ISSN: 0804-4643
Publisher: BioScientifica Ltd.
Other information
Authenticus ID: P-003-TEE
Abstract (EN): Background: We aimed to estimate i) the prevalence of hypercholesterolemia, ii) the proportion of individuals eligible for treatment with lipid-lowering drugs, and iii) therapeutic Success. according to the European guidelines on cardiovascular disease prevention in clinical practice. Design: Population-based cross-sectional study. Methods: We surveyed a representative sample of the population of Porto aged 40-65 years. Trained interviewers collected data from 1215 subjects (789 women) on demographic variables, medical history. and medication using structured questionnaires. A fasting venous blood sample was withdrawn. Subjects were considered low risk or high risk as indicated in the European guidelines. Hypercholesterolemia was defined as total cholesterol (TC) >= 5 mmol/l or low-density-cholesterol (LDL-C) >= 3 mmol/l in low-risk subjects, TC >= 4.5 mmol/l or LDL-C >= 2.5 mmol/l in high-risk subjects or being medicated with lipid-lowering drugs. Eligibility for treatment was defined as being high risk and having TC >= 4.5 mmol/l. LDL-C >= 2.5 mmol/l or being on treatment. We defined therapeutic success as having TC < 4.5 mmol/l and LDL-C < 2.5 mmol/l among medicated subjects. Results: Overall, 84.9% (95% confidence interval (95% CI): 82.7-86.8) of subjects had hypercholesterolemia and 9.1%) (95%, CI: 7.5-10.8) were medicated with lipid-lowering drugs. Men were more likely to be eligible for treatment (42.4%) than women (22.4%; OR = 2.69, 95% CI 2.07-3.52). Therapeutic success was less frequent in men (46.8%) than in women (667%), (OR = 0.39, 95% CI 0.17-0.87). Conclusion: Strict interpretation of the European guidelines would label 85% of the general population in this age group as hypercholesterolemic and a third eligible for drug treatment. Questions arise regarding medicalization, resource allocation, and sustainability within the healthcare system.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 6
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis (2020)
Another Publication in an International Scientific Journal
van Hulsteijn, LT; Pasquali, R; Casanueva, F; Haluzik, M; Ledoux, S; Monteiro, M; Salvador, J; Santini, F; Toplak, H; Dekkers, OM
Non-invasive follicular thyroid neoplasm with papillary-like nuclear feature: clinical, pathological, and molecular update 5 years after the nomenclature revision (2023)
Another Publication in an International Scientific Journal
Melo, M; Ventura, M; Cardoso, L; da Rocha, AG; Paiva, I; Sobrinho-Simoes, M; Soares, P
ENDOCRINE TUMOURS Genetic predictors of thyroid cancer outcome (2016)
Another Publication in an International Scientific Journal
Tavares, C; Melo, M; Manuel Cameselle Teijeiro, JM; Soares, P; Sobrinho Simoes, M
Diagnostic tests for Cushing's syndrome differ from published guidelines: Data from ERCUSYN (2017)
Another Publication in an International Scientific Journal
Valassi, E; Franz, H; Brue, T; Feelders, RA; Netea Maier, R; Tsagarakis, S; Webb, SM; Yaneva, M; Reincke, M; Droste, M; Komerdus, I; Maiter, D; Kastelan, D; Chanson, P; Pfeifer, M; Strasburger, CJ; Tóth, M; Chabre, O; Tabarin, A; Krsek, M...(mais 76 authors)
Cell cycle regulation in adrenocortical carcinoma (2018)
Another Publication in an International Scientific Journal
Pereira, SS; Monteiro, M; Bourdeau, I; Lacroix, A; Pignatelli, D

See all (22)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-24 at 18:25:49 | Privacy Policy | Personal Data Protection Policy | Whistleblowing